The Potential Therapeutic Effect of Orexin-Treated Versus Orexin-Untreated Adipose Tissue-Derived Mesenchymal Stem Cell Therapy on Insulin Resistance in Type 2 Diabetic Rats

Overview

Journal J Diabetes Res

Publisher Wiley

Specialty Endocrinology

Date 2022 Jan 27

PMID 35083338

Authors

Amy F Boushra

Rania H Mahmoud

Shymaa E Ayoub

Rehab A Mohammed

Hanan A Shamardl

Amani M El Amin Ali

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus is a chronic metabolic disease characterized by resistance to peripheral insulin actions. Mesenchymal stem cells have been studied for years in T2DM therapy, including adipose tissue-derived mesenchymal stem cells (AD-MSCs). Orexin neuropeptides (A and B) are well-known regulators of appetite and physical activity. The aim of this work was to elucidate the possible therapeutic effect of AD-MSC preconditioning with orexin A (OXA) on insulin resistance in rats. Twenty-eight adult male albino rats were divided into 4 equal groups: a normal control group and 3 diabetic groups (a control T2DM group, diabetic rats treated by an AD-MSCs group, and diabetic rats treated by AD-MSCs preconditioned with OXA). We noticed that the treated groups showed a significant alleviation of insulin resistance parameters as shown in lowering the serum levels of glucose, insulin, total cholesterol, inflammatory markers, and HOMA-IR as compared to the control diabetic group with more significant reduction observed in the OXA-pretreated AD-MSCs-administrated group. More improvement was also noted in the glucose uptake and GLUT-4 gene expression in the skeletal muscle and adipose tissue in the OXA-pretreated AD-MSCs-administrated group compared to the untreated diabetic group. . Preconditioning of AD-MSCs with OXA can significantly increase their potential to reduce the insulin resistance in the rat model of T2DM.

Citing Articles

Rethinking the Role of Orexin in the Regulation of REM Sleep and Appetite.

Mogavero M, Godos J, Grosso G, Caraci F, Ferri R Nutrients. 2023; 15(17).

PMID: 37686711 PMC: 10489991. DOI: 10.3390/nu15173679.

Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus.

Miklosz A, Chabowski A J Clin Endocrinol Metab. 2023; 108(8):1889-1897.

PMID: 36916961 PMC: 10348459. DOI: 10.1210/clinem/dgad142.

References

Halliwell B . Cell culture, oxidative stress, and antioxidants: avoiding pitfalls. Biomed J. 2014; 37(3):99-105. DOI: 10.4103/2319-4170.128725. View

Campbell R, Cobble M, Reid T, Shomali M . Distinguishing among incretin-based therapies. Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies. J Fam Pract. 2010; 59(9 Suppl 1):S5-9. View

Ueyama A, Sato T, Yoshida H, Magata K, Koga N . Nonradioisotope assay of glucose uptake activity in rat skeletal muscle using enzymatic measurement of 2-deoxyglucose 6-phosphate in vitro and in vivo. Biol Signals Recept. 2000; 9(5):267-74. DOI: 10.1159/000014649. View

Burhans M, Hagman D, Kuzma J, Schmidt K, Kratz M . Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. Compr Physiol. 2018; 9(1):1-58. PMC: 6557583. DOI: 10.1002/cphy.c170040. View

Shree N, Venkategowda S, Venkatranganna M, Datta I, Bhonde R . Human adipose tissue mesenchymal stem cells as a novel treatment modality for correcting obesity induced metabolic dysregulation. Int J Obes (Lond). 2019; 43(10):2107-2118. DOI: 10.1038/s41366-019-0438-5. View

Mushahary D, Spittler A, Kasper C, Weber V, Charwat V . Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 2017; 93(1):19-31. DOI: 10.1002/cyto.a.23242. View

Podell B, Ackart D, Richardson M, DiLisio J, Pulford B, Basaraba R . A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment. Dis Model Mech. 2017; 10(2):151-162. PMC: 5312002. DOI: 10.1242/dmm.025593. View

Adeghate E, Fernandez-Cabezudo M, Hameed R, El-Hasasna H, El Wasila M, Abbas T . Orexin-1 receptor co-localizes with pancreatic hormones in islet cells and modulates the outcome of streptozotocin-induced diabetes mellitus. PLoS One. 2010; 5(1):e8587. PMC: 2799220. DOI: 10.1371/journal.pone.0008587. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

10.

Khan W, Parveen R, Chester K, Parveen S, Ahmad S . Hypoglycemic Potential of Aqueous Extract of Leaf and GC-MS Metabolomics. Front Pharmacol. 2017; 8:577. PMC: 5601078. DOI: 10.3389/fphar.2017.00577. View

11.

Stockert J, Blazquez-Castro A, Canete M, Horobin R, Villanueva A . MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochem. 2012; 114(8):785-96. DOI: 10.1016/j.acthis.2012.01.006. View

12.

Hansen P, Gulve E, Holloszy J . Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol (1985). 1994; 76(2):979-85. DOI: 10.1152/jappl.1994.76.2.979. View

13.

McGrowder D, Ragoobirsingh D, Brown P . Modulation of glucose uptake in adipose tissue by nitric oxide-generating compounds. J Biosci. 2006; 31(3):347-54. DOI: 10.1007/BF02704107. View

14.

Zhao X, Zhang R, Tang S, Ren Y, Yang W, Liu X . Orexin-A-induced ERK1/2 activation reverses impaired spatial learning and memory in pentylenetetrazol-kindled rats via OX1R-mediated hippocampal neurogenesis. Peptides. 2013; 54:140-7. DOI: 10.1016/j.peptides.2013.11.019. View

15.

Suo L, Chang X, Zhao Y . The Orexin-A-Regulated Akt/mTOR Pathway Promotes Cell Proliferation Through Inhibiting Apoptosis in Pancreatic Cancer Cells. Front Endocrinol (Lausanne). 2018; 9:647. PMC: 6220114. DOI: 10.3389/fendo.2018.00647. View

16.

Shree N, Bhonde R . Conditioned Media From Adipose Tissue Derived Mesenchymal Stem Cells Reverse Insulin Resistance in Cellular Models. J Cell Biochem. 2016; 118(8):2037-2043. DOI: 10.1002/jcb.25777. View

17.

Messina G, Dalia C, Tafuri D, Monda V, Palmieri F, Dato A . Orexin-A controls sympathetic activity and eating behavior. Front Psychol. 2014; 5:997. PMC: 4157463. DOI: 10.3389/fpsyg.2014.00997. View

18.

Pagliuca F, Millman J, Gurtler M, Segel M, Van Dervort A, Ryu J . Generation of functional human pancreatic β cells in vitro. Cell. 2014; 159(2):428-39. PMC: 4617632. DOI: 10.1016/j.cell.2014.09.040. View

19.

Deng Z, Xu H, Zhang J, Yang C, Jin L, Liu J . Infusion of adipose‑derived mesenchymal stem cells inhibits skeletal muscle mitsugumin 53 elevation and thereby alleviates insulin resistance in type 2 diabetic rats. Mol Med Rep. 2018; 17(6):8466-8474. DOI: 10.3892/mmr.2018.8901. View

20.

Qi Y, Ma J, Li S, Liu W . Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes. Stem Cell Res Ther. 2019; 10(1):274. PMC: 6712852. DOI: 10.1186/s13287-019-1362-2. View